Mustang Bio

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Mustang Bio and other ETFs, options, and stocks.

About MBIO

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of a broad range of proprietary chimeric antigen receptor engineered T cell (CAR T) immunotherapies and gene therapies. It develops CAR T and CRISPR/Cas9-enhanced CAR T therapies across multiple cancers, as well as lentiviral gene therapy for XSCID. 

CEO
Manuel Litchman
CEOManuel Litchman
Employees
102
Employees102
Headquarters
Worcester, Massachusetts
HeadquartersWorcester, Massachusetts
Founded
2015
Founded2015
Employees
102
Employees102

MBIO Key Statistics

Market cap
49.31M
Market cap49.31M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
440.40K
Average volume440.40K
High today
$0.4898
High today$0.4898
Low today
$0.4418
Low today$0.4418
Open price
$0.48
Open price$0.48
Volume
727.60K
Volume727.60K
52 Week high
$2.82
52 Week high$2.82
52 Week low
$0.4418
52 Week low$0.4418

MBIO Earnings

-$0.32
-$0.21
-$0.11
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 10, After Hours
ActualExpected Nov 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.